Medela Potentia Tbk.

MDLA · Kesehatan · Farmasi & Riset Kesehatan

189

-16.37% 1-year change

Last completed session, Oct 16, 2026

Daily closes over the past year, to Oct 16, 2026

What makes up the 52

  • Value

    73Against 788 other IDX companies

    Cheaper than most comparable stocks.

    P/E
    6.4×
    84%Cheaper than 84% of other IDX companies
    P/B
    0.86×
    61%Cheaper than 61% of other IDX companies
    Dividend yield
    6.7%
    73%Higher than 73% of other IDX companies
  • Quality

    63Against 788 other IDX companies

    More profitable than most comparable stocks.

    Return on equity
    13.5%
    77%Higher than 77% of other IDX companies
    Return on assets
    6.4%
    71%Higher than 71% of other IDX companies
    Net margin
    2.7%
    40%Higher than 40% of other IDX companies
  • Growth

    55Against 788 other IDX companies

    Growing roughly in line with comparable stocks.

    Profit, last 4 quarters
    +12.5%
    54%Higher than 54% of other IDX companies
    Profit, 3-year yearly
    +8.3%
    56%Higher than 56% of other IDX companies
    Profit, latest quarter vs a year ago
    +19%
    54%Higher than 54% of other IDX companies
    Revenue, latest quarter vs a year ago
    +17.6%
    57%Higher than 57% of other IDX companies
  • Momentum

    49Against 836 traded stocks

    Near the middle of the market over the past year.

    1-year price change
    -19.9%
    49%Better than 49% of traded stocks
  • Liquidity

    26Against 836 traded stocks

    Thinly traded compared with most IDX stocks.

    Value traded per day, 30 days
    IDR 221M
    26%Higher than 26% of traded stocks
  • Retail penalty

    −1Retail brokers XL, XC, RO, YP, past 20 sessions

    Retail is underwater here, deeper than 21% of the other stocks where it is, so 1 point comes off the rating.

    Retail average buy
    206
    Close vs that average
    -8.4%
    Retail net bought
    -41K lots

Similar stocks

Rated most like MDLA across the five pillars. Change is over the past year.